Vital medical isotope used in over 40 million procedures each year
A new programme led by Laurentis Energy Partners and BWXT Medical to produce the medical isotope molybdenum-99 (Mo-99) in a commercial operating nuclear reactor for what Laurentis said would be the first time has received regulatory approval of the necessary licence from the Canadian Nuclear Safety Commission.
Want to know more?
Sign up.
- Independent news and information for and about the global nuclear industry
- For nuclear incidents, NucNet operates 24 hours a day, 7 days a week
- Daily, weekly and monthly newsletters
- Access to infographics for subscribers to use in their own editorial and marketing material
- Exclusive analysis and special reports on key nuclear industry topics
- Breaking news on social media
- Access to the 'NucNet Style Guide for Nuclear Reporters and Communicators'
- Access to NucNet editorial database containing more than 18,000 news articles and features from January 1991
- A reliable media and communications partner for the nuclear energy industry. Distribution of your industry news stories
- Manage your own preferences
- Get involved. Members can attend meetings and be part of NucNet's policy and editorial decision-making
Start Free Trial
